Objective: The present investigation was aimed to optimize the formula of paclitaxel-loaded liposomes (PTL) by using the application of response surface methodology (RSM).Methods: Paclitaxel-loaded liposome (PTL) was optimized by response surface methodology based on two parameters, namely, percent entrapment efficiency (% EE) and percent in vitro drug release at 12 h (% DR). The liposome formula was prepared using 32 factorial design, and the selected independent variables were, phospholipid (phospholipon 90G) and cholesterol (CH) concentrations. Nine formulas of paclitaxel-loaded liposome were prepared by thin film hydration technique (THF). The entrapment efficiency, in vitro release studies and drug content, were evaluated using on UV-v...
Liposomesof curcumin was prepared by Thin Film Hydration method (TFH) and Reverse Phase Evaporation ...
In this study the anticancer activity of paclitaxel-loaded nano-liposomes on glioma cell lines was i...
Purpose: To develop liposome formulations containing monoclonal antibody anti-HER2 (MabHer2), and Pa...
Introduction: The present investigation was aimed to optimize the formulating process of sirolimus l...
Objective: The objective of the present study was to formulate and characterize paclitaxel (Ptx) loa...
The purpose of this study was to optimize the preparation conditions of podophyllotoxin liposomes (P...
The objective of this work was to develop and evaluate paclitaxel-loaded liposomal formulations for ...
Objective: This study was aimed to design and characterize Paclitaxel-loaded Solid Lipid Nanoparticl...
In this study the anticancer activity of paclitaxel-loaded nano-liposomes on glioma cell lines was i...
Response surface methodology (RSM) is an effective way to optimize various processes and formulation...
This study aims to investigate the potential of ethanol-based proliposomes in generating paclitaxel-...
Paclitaxel (PTX) is a cytostatic anticancer drug used extensively in wide types of cancer. Due to it...
The objective of these studies was to develop Cremophor-free lipid-based paclitaxel (PX) nanoparticl...
Although the encapsulation of paclitaxel into liposomes has been extensively studied, its significan...
Objective: The purpose of this study was to produce an optimum liposome formulation and to study the...
Liposomesof curcumin was prepared by Thin Film Hydration method (TFH) and Reverse Phase Evaporation ...
In this study the anticancer activity of paclitaxel-loaded nano-liposomes on glioma cell lines was i...
Purpose: To develop liposome formulations containing monoclonal antibody anti-HER2 (MabHer2), and Pa...
Introduction: The present investigation was aimed to optimize the formulating process of sirolimus l...
Objective: The objective of the present study was to formulate and characterize paclitaxel (Ptx) loa...
The purpose of this study was to optimize the preparation conditions of podophyllotoxin liposomes (P...
The objective of this work was to develop and evaluate paclitaxel-loaded liposomal formulations for ...
Objective: This study was aimed to design and characterize Paclitaxel-loaded Solid Lipid Nanoparticl...
In this study the anticancer activity of paclitaxel-loaded nano-liposomes on glioma cell lines was i...
Response surface methodology (RSM) is an effective way to optimize various processes and formulation...
This study aims to investigate the potential of ethanol-based proliposomes in generating paclitaxel-...
Paclitaxel (PTX) is a cytostatic anticancer drug used extensively in wide types of cancer. Due to it...
The objective of these studies was to develop Cremophor-free lipid-based paclitaxel (PX) nanoparticl...
Although the encapsulation of paclitaxel into liposomes has been extensively studied, its significan...
Objective: The purpose of this study was to produce an optimum liposome formulation and to study the...
Liposomesof curcumin was prepared by Thin Film Hydration method (TFH) and Reverse Phase Evaporation ...
In this study the anticancer activity of paclitaxel-loaded nano-liposomes on glioma cell lines was i...
Purpose: To develop liposome formulations containing monoclonal antibody anti-HER2 (MabHer2), and Pa...